|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4900 CAD | -2.00% |
|
-5.77% | +7.69% |
| Jul. 14 | PharmaCorp to Seek Acquisition Opportunities | CI |
| Jul. 14 | PharmaCorp Rx Closes C$11.5 Million Bought-Deal Offering of Share Units | MT |
Main competitors
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| - | - | 49x | - | 1.81x | 18.37x | 40.72x | 60.57M | ||
| -.--% | -.--% | 17.39x | 1.53x | 0.72x | 11.3x | 12.13x | 15.05B | ||
| 2.31% | 2.63% | 16.12x | 1.7x | 0.72x | 7.52x | 9.46x | 5.91B | ||
| 3.11% | 3.43% | 13.78x | 2.07x | 0.88x | 6.37x | 8.34x | 3.9B | ||
| 5.37% | 6.11% | 14.25x | 4.36x | 1.21x | 7.42x | 13.96x | 3.22B | ||
| 4.9% | 5.4% | 14.12x | 2.64x | 0.58x | 4.64x | 7.65x | 3.09B | ||
| 4.39% | 4.81% | 14.62x | 6.61x | 0.88x | 6.64x | 9.23x | 2.96B | ||
| 0.01% | -.--% | -91.83x | 2.89x | 0.46x | 17.01x | 103.36x | 1.51B | ||
| 1.95% | 2.36% | 21.12x | 3.7x | 0.61x | 7.84x | 12.84x | 1.51B | ||
| 4.33% | 4.88% | 11.72x | 0.84x | 0.27x | 2.67x | 5.51x | 928M | ||
| 5.76% | 5.57% | 14.51x | 2.4x | 0.85x | 6.91x | 14.88x | 919M | ||
| 1.38% | 2.01% | 25.87x | 7.05x | 0.94x | 12.77x | 19.79x | 776M | ||
| 0.36% | 0.37% | 14.5x | 1.96x | 0.69x | 8.48x | 13.7x | 705M | ||
| Average | 2.82% | 3.13% | 10.40x | 3.15x | 0.82x | 9.07x | 20.89x | 3.12B | |
| Weighted average by Cap. | 2.1% | 2.33% | 12.19x | 2.54x | 0.76x | 8.89x | 14.53x |
- Stock Market
- Stocks
- PCRX Stock
- Sector PharmaCorp Rx Inc.
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
















